UnitedHealth Group Inc vs Workiva Inc — how do they compare? UnitedHealth Group Inc trades at $379.3 (market cap $332.96B), while Workiva Inc trades at $73.25 (market cap $4.01B). The key difference: UnitedHealth Group Inc is far larger — about 83× Workiva Inc's market cap, and UnitedHealth Group Inc pays a 2.5% dividend while Workiva Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold UnitedHealth Group Inc for 97 Days and Workiva Inc for 21 Days on average.
| UNH | WK | |
|---|---|---|
Market Cap | $332.96B | $4.01B |
Volume | 7,273,749 | 1,301,708 |
Sector | Health | Technology |
52-Week High | $436.35 | $93.31 |
52-Week Low | $259.02 | $44.31 |
Typical Hold Time | 97 Days | 21 Days |
Enterprise Value | $374.82B | $3.99B |
Dividend Yield | 2.5% | — |
Signals from Pluang's Aura AI — not financial advice
UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.
UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.
Workiva (WK) trades at $73.69, up 3.02% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth with 2026 revenue reaching $966 million and net income turning positive at $47 million. Recent earnings beats and AI product innovations at Amplify 2026 conference highlight operational strength. Analyst sentiment remains overwhelmingly positive with 16 buy ratings and an $86 consensus price target.
WK presents a compelling growth story with improving profitability and strong analyst support, though elevated valuation multiples and technical overbought conditions warrant caution. The stock's 88.89% buy rating and 16.7% upside to consensus target suggest continued optimism, but investors should monitor execution of AI initiatives and competitive pressures in the regulatory technology space.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →Workiva is a leading provider of cloud-based platforms for complex reporting and compliance. It enables organizations to connect and manage data across financial reporting, ESG (Environmental, Social, and Governance), and GRC (Governance, Risk, and Compliance), serving as a single source of truth for auditable, transparent disclosures to regulators and stakeholders.
Read more on WK →